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Histological and Immunohistochemical Analyses Used to Study
Craniosynostosis in Pediatric Patients

Palvir Baadh, Phillip McClellan, BS, Robin Jacquet, MS, Ananth Murthy, MD and
William Landis, PhD

The University of Akron, Akron, OH

Abstract
Craniosynostosis is a condition in which one or more of the sutures of the
skull grow together (fuse) earlier than normal in infants. Sutures are large gaps
located at the bony plates or joints of the head. Craniosynostosis causes the
skull to expand and grow in the direction of any normal open suture, creating
craniofacial complications, such as drooping eyelids and abnormal intracranial
pressure, head shape, or brain morphology. This premature fusion or
ossification of sutures affects approximately 300-500 live births in 1,000,000
(Kolpakova-Hart et al., 2008) with considerable variation in phenotype,
depending on which suture(s) is involved. Corrective surgery can be performed
to reshape the skull and eliminate the symptom(s) present in the infant. There is
no known cause of craniosynostosis or direct pattern of heritability from parent to
affected infant and the condition can appear syndromically (associated with
syndrome or condition) or non-syndromically. However, the majority of cases
reported are sporadic, non-syndromic cases, in which pediatric patients suffer
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from premature fusion of only one suture (Levi et al., 2012). In the current
prospective study, histological and/or immunohistochemical analyses have been
conducted on sagittal synostoses as well as patent (normal open suture) tissue
from the skulls of three pediatric patients. Patient surgeries were performed at
Akron Children’s Hospital. The studies were begun to understand more
completely the underlying etiology and possible risk factors of non-syndromic
craniosynostosis. Histological staining, including toluidine blue, hematoxylin and
eosin, and picrosirius red counterstained with alcian blue, has been performed
for qualitatively describing tissue and cell architectural shapes and gross
morphology. Immunohistochemical analysis has also been performed to study
the presence of osterix, a transcription factor essential for osteoblast
differentiation and bone formation. Analytical results of this work are ongoing.

Introduction
Craniosynostosis may affect any of the bones of the human skull.
Eight bones form the neurocranium, which is sometimes referred to as the
braincase. These bones include the single frontal, occipital, sphenoid, and
ethmoid bones and two parietal and temporal bones. These bones together form
the protective case around the brain. The ossification of these flat bones of the
skull occurs when mesenchymal cells differentiate into bone cells (osteoblasts)
through intramembranous ossification, that is, ossification that occurs from
fibrous membranes (Levi et al., 2012). These bones are integrated and unified;
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yet conversely separated by fibrous sutures, where the different bone plates
meet.
The skull of an infant has four sutures, which include the metopic, coronal,
sagittal, and the lambdoid suture. The metopic suture is located where the two
frontal bones on both sides of the skull meet. This suture extends from the top of
the head to the middle of the forehead. The coronal suture occurs where each
frontal bone meets the parietal bones on both sides of the head. This suture
extends from left-most side of the skull to the right-most side of the skull (ear to
ear). The sagittal suture occurs where the two parietal bones meet. It extends
from the middle of the head to the back. The lambdoid suture is found where
each parietal bone meets the occipital bone. This suture extends across the
back of the head horizontally. The suture joints are synarthroses (joints having
little or no movement). During childbirth, they are flexible enough to allow the
skull bones to overlap and absorb mechanical stresses as the baby passes the
birth canal, avoiding damage to the brain (Bronfin, 2001). All four sutures are
very important to the growth of the skull and the brain in the early stages of life.
The patency of these sutures allows brain expansion and formation of the
neurocranium (Levi et al., 2012). If fusion occurs prematurely — before birth or
at birth — between the sutures, the growth of the neurocranium and brain will not
proceed correctly because the centers of growth in the skull are ossified (in other
words, they have become closed). Such a condition is termed craniosynostosis.
It is the premature fusion of one or more of the sutures, which are spaces or
gaps between the bones that comprise the human skull. Surgical intervention of
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the deformity is the only form of treatment to correct premature suture fusion. If
the deformity is not corrected, it will worsen, threatening both the aesthetics and
functional components of the skull of the child.
Nonsyndromic synostoses, those occurring without syndrome, are the most
prevalent form of the craniosynostosis abnormality, affecting the coronal, sagittal,
metopic, or the lambdoid suture or occurring through a combination of the
sutures. Normal development of the skull (calvarium) is dependent on skeletal
bones and synchronized expansion of the brain. Interactions between the bone
plates of the skull, brain, suture mesenchyme, and outer covering of the head,
the dura mater, allow for proper skull growth. It is not known which interactions
are affected in the calvarium that lead to the craniosynostosis phenotypes in
infants. Many mouse and rabbit studies have been conducted to understand this
condition to a better degree, but suture biology is yet largely uncertain. The
exact causative pathways that lead to the condition remain to be discovered and
thoroughly understood.
Research studies focusing on potential causes of nonsyndromic premature
suture closure suggest a variety of factors that could be contributing to the
diseased state, including hereditary, environmental, and/or biomechanical
factors. Extensive research has been done in studying the mutations in proteins
or transcription factors found in craniosynostosis-diseased infants. Causative
mutations in the fibroblast growth factor (FGF), transforming growth factor beta
(TGFß), and twist (TWIST1) families as well as runt-related transcription factor 2
(RUNX2), osteoblast-specific signaling proteins and transcriptions factors (TFs)
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have each been identified individually in studies using nonhuman models and
have been linked to craniosynostosis pathology (Connerney et al., 2008 and
Morriss-Kay et al., 2005). Of particular interest to the study researched here is a
novel zinc-containing transcription factor, osterix, which is essential for osteoblast
differentiation and bone formation and has not been investigated previously in
human tissue.
Osterix is a transcription factor (Sp7) fundamental for osteoblastogenesis and
bone formation in mice (Zhu et al., 2012 ). Null mouse mutants that lack osterix
will die just hours after birth because there is a deficiency in intramembranous
and endochondral ossification in their bodies (Baek et al., 2009). The
consequence of death is indicative of the significance of osterix and its role in
vertebrate bone formation. Genomic studies also show that osterix is
responsible for bone density in humans (Zhu et al., 2012).
Osterix-expressing cells produce Wnt protein and respond to Wnt
signaling (Tan et al., 2014). Wnt represents both a signaling molecule and a
signaling pathway and Wnt critically regulates bone development. It has been
shown that, if Wnt secretion in vivo is inhibited, inappropriate bone differentiation
and diminished bone proliferation take place along with a reduction in Wnt
signaling. Consequently, osterix-expressing cells produce Wnt proteins that
induce Wnt signaling responses regulating proliferation and differentiation of
bone (Tan et al., 2014). Furthermore, recent craniosynostosis research
conducted at the University of Pittsburgh studied development of the skull bones
of mice in response to increased Wnt signaling (Szabo-Rogers et al., 2014).
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The work found that differentiation of osteoblasts and osteogenesis were
increased in the mouse frontal bones (Szabo-Rogers et al., 2014). These
findings are very important to this present craniosynostosis study because they
suggest that, if osterix inactivation can lead to delayed osteoblast maturation and
reduced bone formation in mice, perhaps the overexpression or up-regulation of
the osterix transcription factor can affect Wnt signaling. This possibility could
lead to increased osteoblast differentiation and formation of bone. In this
manner, osterix can play a significant role in early vertebrate suture formation.

Figure 1: A schematic diagram showing that Wnt
signaling occurs after the expression of osterix for
mature osteoblast differentiation (Day and Yang,
2008).
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The goal of this project is to investigate the morphology, structure, and
biochemistry of fused suture sites by using light microscopy, histology and
immunohistochemistry (IHC). The specimens to be investigated are affected
sagittal synostosis tissues and unaffected, open coronal tissues (controls) from
infants of different ages. For histology, various stains were utilized to facilitate
microscopic study and identification of cellular components and arrangement of
cells inside the diseased craniosynostosis and normal samples. The stains were
also applied in some cases to provide biochemical information about the
samples.
Toluidine blue was the principal stain used. It highlights nuclei acids such as
DNA and RNA because it is a basic thiazine metachromatic dye with high affinity
for acidic tissue components. As such, toluidine blue can distinguish between
tissues, in this case, the scaphocephaly (sagittal synostosis) and open sutures
(control). Hematoxylin and eosin was another stain used in this analysis.
Hematoxylin stains nuclei of cells a deep blue color and binds to basophilic
substances. The counterstain, eosin, binds to acidophilic substances such as
proteins and cytoplasmic material and turns them red or pink. Compared to a
single stain, counterstains provide better visualization of cells and cell structures.
A picrosirius red and alcian blue stain was also applied. Picrosirius red allows
histological visualization of both Type I and II collagen, whereas alcian blue
stains acidic polysaccharides, for example, glycosaminoglycans in cartilaginous
bones.
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IHC examination of osterix transcription factor was conducted in the diseased
tissues. IHC is a method of applying antibodies for identifying proteins specific to
a histological sample, in this case the affected and normal sutures. By using IHC
methods, the identification and the presence or location of the osterix
transcription factor in tissue sections were made through antibody binding to this
protein. These histological and IHC studies have demonstrated thorough
investigation of the tissues in question and provided scientific insight into the
pathology.

Material and Methods
Cranial suture specimens were obtained from craniosynostosis patients who
underwent corrective surgery at Akron Children’s Hospital, Akron, OH. Affected
and normal tissue from the skull were collected and used for research purposes
in compliance with Hospital regulation and approval from the parent(s) of the
patients. Sagittal suture specimens from three different patients were collected
over the course of two years (2013-2014). The ages of the patients were two
(Specimen 3) and four months (Specimen 4) with one age unknown (Specimens
1 and 2). All patients suffered from nonsyndromic craniosynostosis and were
sporadic (unpredicted) cases. Specimens 1-2 were taken in surgery at the Akron
Children’s Hospital in May, 2013, and placed in 10% neutral buffered formalin
(NBF, VWR, Radnor, PA) at 4°C until research studies were begun two months
later in the Department of Polymer Science at the University of Akron. Specimen
3 was obtained in July, 2013, and also stored in NBF at 4°C until histological

9
analyses were performed in November of the same year. Specimen 3 was
obtained from a male, three-month-old child. Specimen 4 from a four-month-old
male was received in April, 2014, and stored in NBF at 4°C until histological
analyses were conducted weeks later.
Histological Analyses
Sample dimensions and location. Specimens 1-4 were each of different
sizes and shapes obtained from surgery. They were measured in length and
width as 4 cm X 0.5 cm, 2 cm X 0.5 cm, 12 cm X 5 cm, and 9.5 cm X 3.5 cm,
respectively. Specimens 1-4 were all sagittal synostoses; specimen 3 also
contained open coronal and lambdoid sutures; and specimen 4 contained an
open coronal suture. The open coronal and lambdoid sutures in specimens 3-4
were unaffected by the synostosis and served as experimental controls to the
affected, closed (fused) sagittal regions.
Based on the tissue appearance and its hardness, specimen 1 was
subdivided with a scalpel blade into three regions: ossified, partially ossified, and
lacking ossification. Specimen 2 was similarly divided, but only into ossified and
partially ossified regions because of its short length. Specimen 3 was divided into
five areas of interest, sagittal anterior and posterior (partially ossified), sagittal
center (ossified), and a coronal and lambdoid region. Specimen 4 was cut into
ten areas, six sagittal and four coronal. Of the sagittal sutures, three adjacent
regions (anterior, central, and posterior) were themselves subdivided equally into
anterior and posterior portions. Of the coronal sutures, two opposing regions

10
were each subdivided equally into medial and lateral portions. Images of some
of the specimens are shown below.

Figure 2: Photographs illustrating general overview of specimen 1 (upper left
panel), specimen 2 (lower left panel), specimen 3 (upper right panel), and
specimen 4 (lower right panel) obtained following surgery. Samples were later
subdivided and processed.
Fixation and decalcification. Specimens 1-4 were each fixed in 10% NBF
at 4°C. Specimens 1 and 2 were fixed for approximately two months and
specimens 3 and 4 were fixed for 4 months and 1 month, respectively.
Specimens were then divided using a scalpel blade (Specimen 1 and 2) or a
Dremel Rotary Tool (Bosch Corp., Stuttgart, Germany) (Specimen 3 and 4) into
their individual parts based on sample hardness and appearance. Following
fixation, all specimens were divided as described above. NBF solution was
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removed from all divided specimen samples with deionized water (DI H2O).
Three washes, ten minutes each, were used with a rotary shaker (Rotoshaker
Genie, Scientific Industries, Bohemia, NY). After the final wash was finished,
70% ethanol (Cat. No. 2701, Decon Laboratories, Inc., King of Prussia, PA) was
added to the containers holding the several divided specimen samples.
Containers were stored in a 4°C refrigerator until the following day when the
washes were repeated. Samples were decalcified initially in 100% Immunocal
(Decal Chemical Corp., Sufferin, NY) for 24 (samples from Specimens 1 and 2)
or 72 hours (samples from Specimens 3 and 4) on the rotary shaker at room
temperature. Hardness of each tissue sample was detected with a needle and
samples were decalcified further if they were hard. To complete the
decalcification process, a 50:50 solution of Immunocal and NBF was prepared,
and samples were transferred from 100% Immunocal to the 50:50 solution.
Samples from Specimens 1-2 and 3-4 were additionally decalcified 1.5 and 24
hours, respectively. Samples were tested again with a needle to detect hardness
of the suture tissue and were found to have decalcified adequately. To remove
Immunocal-NBF solution, three DI H2O washes, fifteen minutes each, were done
using the rotary shaker and three, 70% ethanol washes, fifteen minutes each,
removed the remaining water. The samples were stored in the last ethanol wash
at 4°C.
Processing. The processing steps were identical for all samples. Samples
were removed from the 4°C refrigerator and from their containers having 70%
ethanol. Samples were placed into plastic cassettes, which were labeled to
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identify their individual tissue and its corresponding region. The cassettes were
next placed into a tissue-processor (Leica Asp 300s, Buffalo Grove, IL) and left
over the weekend to complete the processing cycle of a series of automated
washes in preparation for sample embedding.
Embedding. The embedding procedure was the same for all samples. After
processing, individual tissues were quickly removed from the processor and
immediately embedded into paraffin wax blocks using a tissue embedder (Leica
EG 1150C, Buffalo Grove, IL). Samples were embedded in wax molds with their
anterior portion (in relation to the anatomy of the skull) at the bottom of the mold.
This orientation was necessary so that, when serial sections were prepared, they
would be cut anterior-to-posterior and their regional identity would be recognized.
The thinnest dimension of each sample was also oriented toward the bottom of
the mold. After wax was poured over the samples, embedded molds were set on
a cooling plate (Leica EG 1150C, Buffalo Grove, IL) to allow the wax to solidify.
After ten minutes, hardened paraffin wax blocks containing the samples were
stored in a -20°C freezer to allow the blocks to harden.
Sectioning. Samples were all treated identically when sectioning. Wax
blocks were removed from the -20°C freezer and placed in a -80°C freezer to
supercool wax blocks overnight before sectioning. This procedural step helped
harden the blocks and aided sectioning. Wax blocks were then removed from
-80°C and were sectioned using an automated microtome (Leica RM 2255,
Buffalo Grove, IL). Sections were cut at 6 µm thicknesses using a tungsten
carbide blade. Wax blocks were trimmed and then serial (consecutive) sections
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were prepared. Surface decalcification was utilized for blocks that produced
shredded sections. Sections were floated on a water bath (Leica HI1210,
Thermo Scientific, Portsmouth, NH) and then transferred to Superfrost Excell
slides (Thermo Scientific, Portsmouth, NH). Slides were labeled accurately and
allowed to dry in air overnight in a vertical position.
Staining. Various basic stains were used to highlight and examine structural
components of the suture tissue. The stains utilized in this study were
hematoxylin and eosin, toluidine blue, pircosirus red, and pircosirus red
counterstained with alcian blue.
Preparation of Stains. Hematoxylin and eosin (H&E) stain was applied to
samples obtained from specimens 1 and 2 (Figure 2). Hematoxylin is a stain
used for nuclear detail, while eosin serves as a contrasting counterstain for
extracellular substances. A progressive staining procedure was used in which
slides were stained with hematoxylin, rinsed, and then counterstained with eosin.
The following materials were used to prepare the H&E stain: Hematoxylin, eosin
Y, weak acid deionized H2O (0.3% HCI), and weak basic NH4OH (0.5% NH4OH;
also known as bluing agent). These reagents were mixed over a stir plate and
then stored at room temperature.
Toluidine blue (T-blue) stain was used for samples obtained from specimens 1
and 2 in this study. Toluidine blue is a thiazine metachromatic dye that stains
acidic tissue components. This dye stains nucleic acid material blue and
polysaccharides purple. For this stain 0.1% toludine blue solution was made.
Toluidine blue powder (FisherBiotech, Fair Lawn, N.J.) was measured to 0.5 gm
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and 500 mL of milliQ water was added. Stain was then mixed over a stir plate
and stored at room temperature.
Picrosirus red (PSR) was another stain utilized in this study. Staining was
performed on samples obtained from specimen 1 and 2. PSR is intended for
visualization of collagen fibers (types I and II). Collagen stained with PSR is
visible by both normal and polarized light microscopy (birefringence). PSR stains
collagen fibers red and cell cytoplasm and muscle fibers yellow. For preparation
of this stain, Sirius red F3B (C.I. 35780, Pfaltz and Bauer Inc., Waterbury, CT)
was measured to 0.5 gm and 500 mL of an aqueous solution of picric acid was
added and mixed on a stir plate. Acidified water was also prepared by
measuring 5 ml of acetic acid and adding it to 995 mL of deionized water.
Picrosirus red and alcian blue stains were utilized for samples obtained from
specimen 3 (Figure 2). The purpose and preparation of picrosirus red stain are
explained in the previous paragraph. Alcian blue stain is intended for
visualization of sulfated and carboxylated acid mucopolysaccharides and sulfated
and carboxylated sialomucins (glycoproteins). A 3% glacial acetic acid solution
was prepared by adding 9 mL of acetic acid to 300 mL of deionized water. The
3% acetic acid solution was added to 3 gm of Alcian Blue 8GX powder (Sigma
Chemical Co., St. Louis, MO), creating a 1% alcian blue solution. The solution
was then mixed over a stir plate and pH adjusted to 2.5 using acetic acid. Stain
was then stored at room temperature.
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Staining procedure.
Deparaffinizing, clearing and hydration. All prepared slides were placed in an
oven at 58°C for a minimum of 2 hr to deparaffinize sections. Three changes of
xylene (EK Industries, Joliet, IL) washes, 5 min each, were carried out in the
fume hood. A change of 100% ethanol for 2 min was then done, followed by a
95% ethanol wash for 2 min. Two changes in 70% ethanol were done for 2 min
each. Distilled water rinse for 2 min followed.
Staining process for hematoxylin and eosin. Slides were stained in filtered
hematoxylin for 5 min and then destained in 0.5% HCI (freshly prepared in water)
for 20 sec. Slides were then briefly rinsed in running deionized water and slides
were dipped in water five times. Slides were then washed in 0.5% ammonium
hydroxide (bluing agent) for 30 sec, which was also freshly prepared. Slides
were then washed in 95% ethanol for two min. The counterstain eosin Y was
then applied for 1 min.
Staining process for toluidine blue. Slides were immersed in freshly filtered
0.1% T-blue stain for 1 min. Slides were then dipped in freshly distilled water five
times.
Staining process for picrosirius red. Slides were placed in a staining dish
containing picrosirius red stain for 1 hr. Slides were then washed in two changes
of acidified water for 2 min each.
Staining process for picrosirus red and alcian blue. Slides were placed in
0.5% acetic acid solution for 10 min, removed, and then placed in 1% alcian blue
stain (pH 2.5) for 10 min. Two washes of 0.5% acetic acid solution followed for 3
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min each. Slides were placed into a staining dish containing 0.5% picrosirius red
counterstain for 1 hr. Two 0.5% acetic acid rinses (ten dips) were then
performed.
Dehydration, clearing and mounting slides. After completing the staining
process, two changes of 95% ethanol for 1 min each were conducted. Two
changes of 100% ethanol for 1 min each followed. Slides were put through three
xylene washes (5 min each) before being mounted and coverslipped with DPX
Mounting Medium (Cat. No. 13512, Electron Microscopy Sciences, Hatfield, PA).
Slides were allowed to dry overnight in a horizontal position before microscopic
examination.
Immunohistochemistry for paraffin-embedded tissue sections (IHC).
This technique was applied to samples obtained from specimen 4 (Figure 2).
IHC detects an antigen (protein of interest in cells) in tissue sections by antibody
binding. IHC provides the identification of the location and distribution of specific
proteins in the tissue section. In this research analysis, the osterix protein was
studied by IHC.
Deparaffinizing, drying, rehydration and fixation. Prepared slides were placed
in an oven at 58°C for 4 hr to deparaffinize the sections. Three changes of
xylene (EK Industries, Joliet, IL) washes, 10 min each, were carried out in a fume
hood. Two changes of 100% ethanol for 5 min each were done. Slides were
then placed into 95% ethanol twice for five minutes each. Slides were then
removed from solution and placed on a countertop and dried with a heat gun
(cold air setting) for 10 min. The heat gun setting was changed to hot air and
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slides were dried for additional 10 min. The cold-hot drying was repeated for 5
min each to complete this four-process sequence. Two changes of milliQ water
followed for 5 min each to rehydrate the sections. Slides were then placed in
10% NBF for fixation overnight at room temperature.
Epitope (antigen) retrieval. Slides were removed from NBF solution and two
changes of deionized water, five minutes each, were made. Two 100%
Immunocal washes (1 hr each) followed. Again, slides were washed twice with
deionized water for 5 min each. Slides were then placed into a dish containing
epitope retrieval solution (see below) and the dish was placed in a 60°C waterbath for 72 hr.

Figure 3: Illustration of slides (blue) in a covered staining dish (dark grey
box) containing epitope retrieval solution. The slide box sits in a water
bath, heated to 60°C, within a larger box (light grey). The blue line in the
illustration indicates the water level.

The water in the bath was checked during the 72 hr time frame to maintain its
appropriate level. Epitope retrieval solution was prepared by adding 1.47 gm of
sodium citrate, 0.37 gm of ethylenediaminetetraacetic acid (EDTA), and 0.25 mL
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of Tween 20 to 500 mL of H2O and with stirring on a stirplate. The pH was
adjusted to 6-6.5. hydrogen chloride.
Application of primary antibody. Slides were cooled by adjusting the water
bath to 20°C. Slides were maintained in a hydration state for further processing.
Slides were washed twice with phosphate-buffered saline (PBS) solution for 5
min each. Slides were removed from PBS and placed individually on a
countertop. Two-three drops of Background Buster Blocking Agent (Innovex
Biosciences, Richmond, CA) were immediately applied to the slides for 30 min to
block endogenous tissue sites of possible antibody binding. The blocking agent
was removed quickly by drainage from the slide and primary osterix antibody
(dilution factor: 50 micrograms of antibody to 1 mL of diluent) was applied. Other
slides were processed in the same manner except that they were treated with
Tris-buffered saline and Tween 20 (TTBS) in place of the osterix antibody (these
slides served as negative controls). Slides were left overnight at 4°C.
Peroxide/Methanol block, DAB, hematoxylin staining, and mounting slides.
Three washes of TTBS were applied for 5 min each. ImmPress Reagent
Peroxidase (2nd antibody) (Vector, Burlingame, CA) was applied to all slides for
30 min. Again, three washes of TTBS identical to those noted above were
performed. A 30% methanol hydroxide and 0.3% hydrogen peroxide (H2O2)
block for applied for 10 min. Three TTBS washes followed for 5 min each. 3,3diaminobenzidine (DAB) peroxidase was applied to slides for up to 2 min. Once
brown coloration was seen on slides, DAB was removed and slides were quickly
placed in a dish containing PBS solution. To prepare DAB peroxidase, a
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MaxTag DAB tablet (Rockland Immunochemicals, Inc., Gilbertsville, PA) was
added to a non-light-penetrating test tube and PBS was added to the 7 mL mark
of the tube. DAB was dissolved thoroughly in PBS solution and stored on ice
until needed for use. Immediately prior to application, 2-3 drops of H2O2
(activator of DAB) were added to the test tube and the tube was shaken. Slides
were then washed with PBS two times for 5 min each. Mayers hematoxylin (Cat.
#26252-01, Electron Microscopy Sciences, Hatfield, PA) was used to stain slides
for 1 min. Slides were placed under running deionized water for 4 min. Slides
were then dipped in bluing reagent ten times consecutively. The following
alcohol washes were then used in order: two 70% ethanol washes, two 95%
ethanol washes and two 100% washes. Each wash was timed for 2 min. Three
xylene washes were then used, each 5 min. Slides were mounted and
coverslipped and left to dry in a vertical position.
Microscopy. In this study, an Olympus 1X70 (Olympus America, Center
Valley, PA) light microscope combined with Olympus MicroSuite Software for
Imaging Applications was utilized to view sections. Slides were cleaned with a
KimWipe (Kimberly-Clark Professional, Roswell, GA) and then placed on the
microscope stage. The large and small coarse focus knobs of the microscope
were adjusted until the image appeared clear. Adjacent areas of each slide were
scanned and imaged section-by-section and saved onto a USB drive. Images
were taken at 4X magnification and a scale bar was superimposed on each
image. Saved images were stitched together using Microsoft Image Composite
Editor and montage images were compiled and stored. Sufficient overlap
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between images was maintained for proper stitching of consecutive images.
Stitching images in this manner helped maintain clarity of the full section and its
resolution.

Results
Basic dyes such as T-blue, H&E, and PSR were used to assess
craniosynostotic diseased tissue obtained from the specimens of interest, in this
case specimens 1 and 2. Results indicated different patterns of morphology
between specimen areas that were identified as ossified, partially ossified, and
absent of ossification. These regions were classified based on their position and
location in relation to the anatomy of the skull before being dissected and
sectioned. The ossified regions of specimens 1 and 2 were osteogenic centers
that had undergone premature fusion of the skull. These center-ossified regions
were of particular interest in this study and therefore they were compared to the
other two skull areas (partially ossified and absent of ossification) to study
regional differences in bone anatomy. Figure 4 shows that bone in the ossified
skull region had more marrow space in comparison with it counterparts and also
demonstrated that osteocytes trapped in lacunae were more numerous and
indicative of ossification in these samples. Below are images of the various
stains of specimens 1 and 2 showing gross morphology and anatomy of the
affected suture tissue.
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Figure 4: T-blue-stained images of specimen 1 depicting three different regions
of the sagittal suture from a patient of unknown age or gender. Top left: There
is little or no ossification in this part of the specimen. Top right: Another area of
the same specimen is partially ossified as determined by its hardness. Bottom
center: A third area of the specimen is ossified, again determined by its
hardness. T = Trabeculae, M = Mineral. Scale bar in all images = 500 µm.
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Figure 5: T-blue stained images of specimen 2 (obtained from a patient of unknown age
and gender) depicting a partially ossified (left) and ossified region (right) of the suture.
Both images show the fully transverse suture region. Right image is a series of separate
photomicrographs that have been stitched together with ICE Software. Scale bars in left
and right image are 500 µm and 1 mm, respectively.

Figure 6: H&E-stained images of Specimen 1 taken from different areas of suture
tissue. The left, middle, and right images, each stitched from numerous
photomicrographs, display an area absent of ossification, a partially ossified region,
and an ossified region, respectively. Scale bar in all images = 1 mm.
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Figure 7: H&E-stained images of specimen 2 illustrating a partially ossified (left) and an
ossified region (right) of the suture tissue. The left side of the ossified image faces the
dura mater of the skull, while the right side faces the skull periosteum side. Scale bars
in left and right image are 500 µm and 1 mm, respectively.
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Figure 8: PSR-stained images of specimen 1 showing particular areas of
suture tissue, an ossified region (top left), a partially ossified region (top
right) and an area lacking ossification (bottom center). Scale bar in all
images = 500 µm.

In all stained ossified, closed regions obtained from sagittal sutures,
mineralized bone trabeculae were more apparent than in stained partially ossified
regions and regions absent of ossification. Partially ossified regions and regions
absent of ossification displayed fibrous tissue having little or no trabecular
formation, an observation indicating that areas have not fully undergone
intramembranous ossification. Trabecular bone, also known as cancellous bone,
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is usually highly vascularized, a fact which explains the large marrow spaces in
the ossified regions compared to the other two regions (Figure 8). Flat bones,
such as those of the skull, receive a superficial blood supply from the periosteum,
which is needed for proliferation of bone cells. This additional fact could be the
very reason that many marrow spaces are present in the ossified regions
indicative of blood vessels and capillary blood supply needed for growth.
In Figure 7, the ossified region displayed an interesting pattern at its
periosteum side. The mineralized bone trabeculae appeared to follow a
particular arrangement and run parallel to each other. The architecture and
arrangement of the bone tissue seemed unique in the sense that small-elongated
holes line the periosteum surface and gradually diminish in size deeper into the
tissue. These holes near the periosteal surface of the suture were different from
the deepest tissue regions where prominent large holes form trabecular bone.
The reasons for the presence of these two distinct types of holes in the sutures
are not clear, but the differences between the periosteum and trabecular bone
could be where underlying premature ossification originated because of
mechanical stress on the suture tissue.
Suture fusion results from intramembranous ossification. This process
includes the appearance of an ossification center in the fibrous connective
membrane region and secretion of bone within the fibrous membrane to form
woven bone (immature trabecular bone). Woven bone is later remodeled to
create lamellar bone (mature bone). Figure 9 shows both lamellar and trabecular
bone. The lamellar bone in this figure appeared organized and stress-oriented,
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two characteristics of lamellar bone in general. Moreover, when the ossified
region of specimen 2 was viewed under higher magnification using a polarized
light microscope, lamellar organization reflected a repeating pattern of bright and
dark bands of collagen fiber architecture. This patterning is suggestive of mature
lamellar bone present in the tissue sample (Figure 10).

Figure 9: PSR-stained images of specimen 2 depicting an ossified suture
region. Left image is a view under polarized light and right image depicts the
ossified region with normal light microscopy. Polarization shows presence of
collagen. Scale bar in all images = 1 mm.
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Figure 10: Ossified region of specimen 2 viewed using polarized light
microscopy. Presence of collagen is indicated by birefringence (bright
yellowish-red and green appearance) in this closed suture tissue. There is a
repeating pattern of bright and dark bands in some areas of the section
(arrows). Scale bar = 500 µm.

Picriosirius red, a stain utilized in this study, was applied for histological
visualization of type I and III collagen fibers. Under polarized light, collagen
fibers found in the tissue appeared bright red-orange and green and could be
distinguished from the non-collagenous background material, which appeared
black. Because bone is composed of roughly 30% organic compounds, of which
collagen constitutes about 90%, the presence of collagen provides the principal
supporting framework of the suture.
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Specimen 3, obtained from a two-month-old child, was divided into five areas
of interest, sagittal anterior and posterior (partially ossified), sagittal center
(ossified), and a coronal and lambdoid region, and was stained using picrosirius
red and alcian blue to assess tissue morphology. This stain was useful for
visualizing the suture site and its surrounding areas where bone was thought to
be deposited.

Figure 11: Sagittal posterior, partially ossified region of specimen 3 stained
using picrosirius red and alcian blue stain and viewed using light microscopy.
The area depicts a possible fusing suture shown by the prominent gap found
in the tissue and indicated by the arrow. There is also the presence of several
thin, parallel layers of cortical bone adjacent to trabecular bone. Scale bar = 1
mm.

Interestingly, the sagittal posterior (partially ossified) region of specimen 3
displayed an organized layering pattern on its periosteum side, while trabecular
bone appeared deeper into the suture (toward the dura mater). The tissue also
exhibited a region where it seemed that parietal bone plates were meeting and
undergoing fusion. This feature can be seen by a distinctive gap in the tissue
(Figure 12).
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At the microscopic level, flat bones of the skull have outer compact bone
layers, one layer toward the periosteum and the other toward the brain.
Cancellous (trabecular) bone occupies the center region between the two layers.
The results obtained from picrosirus red and alcian blue staining demonstrated
these two types of bone, trabecular and compact, present in the cranial suture
tissue (Figure 12). The compact bone could be forming at the site of suture
fusion, a possibility that is supported by results shown in Figure 13.

Figure 12: This figure depicts photomicrographs obtained from a surgical sample of
a male, three-month-old child (specimen 3) and stained with picrosirius red and
alcian blue. The first, second, third, and last micrographs depict a coronal, a sagittal
center (ossified), a posterior (partially ossified) and a lambdoid suture region,
respectively. Note that an anterior sagittal suture is not depicted. Scale bar = 1 mm.
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Figure 13: Enlargement of Figure 11, the sagittal posterior, partially ossified suture
region displaying a layering pattern of cortical bone (C) near the periosteum surface
with a possible open, unfused area (S) in the center of two opposing parietal bone
plates (P). Trabecular bone (T) is deposited deeper into the tissue. Scale bar =
500 µm.
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The gap that appeared within the layered cortical bone evidently depicted an
area of the suture tissue that was open and undergoing ossification (Figure 11).
It is presumed that the suture joint would eventually ossify when parietal plates
met from opposing sides. Once the bone ossified, the suture would disappear
and would leave no trace of the suture site. This open region normally provides
continued growth of the skull but such regions are diminished or lost in premature
suture fusion, as previously noted. Once a suture site disappears, it becomes
impossible to identify its location in the ossified tissue. This result explains why
suture sites cannot be identified in other closed areas of the surgical specimens
examined in this study.

Figure 14: Image taken from a lambdoid suture region showing periosteum
surrounding the outside of the skull bone (toward the skin), as indicated by the
arrow. The periosteum is a layer of dense connective tissue and is fibrous
externally (toward the skin) but becomes more vascularized and cellularized
near the bone tissue. Scale bar = 500 µm.
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Trabecular bone is known to be very sensitive to external forces and provides
the remarkable strength of the skull. This type of bone is extremely porous and
forms the inner area of the skull bones, whereas compact (cortical) bone forms
the outer layers. This description agrees with the histological results obtained in
this study using picrosirius and alcian blue staining. All areas of interest, sagittal
anterior and posterior (partially ossified), sagittal center (ossified), and a coronal
and lambdoid region, displayed this type of tissue arrangement, where the
periosteum side of the samples contained cortical bone and inner bone layers
were trabecular (Figure 12).
Osterix, a zinc-finger containing transcription factor essential for forming bone,
was identified and localized in cranial suture tissue in specimen 4. Osterix is
specifically found in the nucleus of cells undergoing the transition between
mesenchymal stem cells and osteoblasts, as it is a protein that plays a role in the
transcription of other important proteins vital to bone development and the
differentiation of mesenchyme cells into osteoblasts. Figures 15 -18 are images
of osterix immunohistochemical staining of a posterior, sagittal suture region from
a four-month-old male. The staining demonstrates the presence of osterix in
cells transition to osteoblasts of this developing suture tissue. Counterpart
sagittal suture sections treated without primary antibody to osterix were negative
controls and they showed no specific staining for osterix (Figures 15 -16). Such
negative controls verify that the immunostaining of osterix is real and not the
result of a nonspecific reaction.
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In detail, immunostaining results indicated the presence of osterix in cells
lining the surfaces of trabecular bone and the absence of osterix in cells of
cortical bone (Figure 15). 3,3’-diaminobenzidine (DAB) staining was present also
within posterior portions of the trabecular bone of sagittal sutures, a result
indicative of osterix and thus osteoblast activity in this suture region (Figure 15).

Figure 15: Immunohistochemistry of osterix-stained images from a fourmonth-old male (specimen 4), showing posterior portions of a sagittal suture.
The image on the left shows a negative control test area where DAB staining
for osterix is absent because no primary antibody was applied to the tissue.
The image on the right shows a region of the posterior, sagittal suture reacted
with primary antibody. DAB staining (brown) is present in this suture region
within osteoblasts lining the trabecular bone (arrows) and within cells found in
marrow spaces (arrowheads). Scale bar = 500 µm.

On comparison of negative control test slides and experimental slides,
mesenchymal stem cells (MSC) were found to be present in the marrow space in
both (Figure 16). In the negative controls, the MSCs stained blue with
hematoxylin, whereas in the experimental slides MSCs stained brown (DAB
staining) as well as blue, an observation that verified the presence of osterix.
This finding was notable in that it supported the notion that intramembranous
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ossification was occurring. MSCs are progenitor cells that may become
osteoblasts under certain conditions, and osterix staining demonstrated the
transition from MSCs to osteoblasts in the marrow spaces. These osteoblasts or
their precursors appear to form a nidus, a dense cluster of cells within the
marrow spaces. Differentiated osteoblasts, stained brown for osterix, are lining
the trabecular surfaces of the suture (Figure 16).
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Figure 16: Posterior portions of a sagittal suture from a four-month-old male stained
without (upper panel) and with (lower panel) DAB to demonstrate osterix. Images
are taken from the same region of the specimen but different areas within the tissue.
Aggregation of mesenchymal stem cells appears in the marrow space as can be
seen by the cluster of cells in the center of the tissue. The nidus of aggregated cells
in the marrow space in the lower panel is composed in part by DAB-stained cells
transitioning from MSCs to osteoblasts. Differentiated osteoblasts line the trabecular
bone as indicated by the arrows. Scale bar = 500 µm.
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Figure 17: Posterior portions of a sagittal suture from a four-month-old
male stained with DAB to demonstrate osterix. The image shows osterix
staining in the marrow spaces of the tissue. T = trabecular bone. M =
marrow space. OSX = osterix stain. O = osteocytes. Scale bar = 500 µm.

36

T
C

Figure 18: Posterior portions of a sagittal suture from a four-month-old male
stained with DAB to demonstrate osterix. The DAB stain remains particular to
the osteoblasts lining the trabecular bone region and is absent in cells within
cortical bone. C = cortical bone. T= trabecular bone. Scale bar = 500 µm.
Overall, the novel finding of osterix in the suture tissue from specimens of
craniosynostosis supports the concept that osteoblast activity and bone formation
occur in or around the closing suture. As a transcription factor, osterix acts as a
marker for osteoblast differentiation and proliferation in postnatal bone formation
of the skull. Additionally, the absence of osterix expression in cortical bone and
the presence of osterix in cells lining the surfaces of trabecular bone as well in
cell aggregates within trabecular bone marrow spaces are new findings.

Discussion
Craniosynostosis, the premature fusion of the suture(s) in pediatric patients, is
a pathological condition that remains ambiguous and incompletely understood.
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Although studies with syndromic (with known condition) craniosynostosis have
identified genetic factors associated with this condition, little is known about the
nonsyndromic form of craniosynostosis. This research study intended to
understand more thoroughly cranial suture biology and the deformational factors
leading to the diseased phenotypes in nonsyndromic forms of craniosynostosis.
Results of gross morphology and histology of affected suture tissues were
obtained to provide structural and architectural information about the specimens.
In addition, immunohistochemistry of osterix yielded the preliminary result that
this transcription factor was associated with cells in aggregates within marrow
spaces of the tissues as well cells lining the trabecular areas of the sutures. The
presence of DAB-positive cells in marrow spaces provides evidence that MSCs
transition to osteoblasts in these trabecular bone regions. Cells lining the
trabecular suture areas are also DAB-positive and here they are functional,
differentiated osteoblasts. Further, osterix expression is absent in cortical bone.
The findings of osterix in osteoblasts at the trabecular surfaces of the sutures
and in cell aggregates within marrow spaces of trabeculae have not been
reported previously. These results provide new insight into craniosynostosis and
cranial suture biology.
Future studies will examine osterix immunohistochemistry more completely to
understand the formation of trabecular bone in additional sagittal sutures affected
by craniosynostosis as well as synostoses in other bones of the skull. Efforts will
also be made to quantitate expression of osterix in diseased tissue, so
comparisons could be made to control tissue regions (normal suture areas
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extracted alongside fused regions during surgery). If expression levels of the
osterix protein were abnormally higher in fused suture regions compared to that
of open regions, then it might be concluded that high osterix expression plays a
role in suture closure. If such were the case, proteins upstream of osterix would
also be analyzed and would include Indian Hedgehog (IHH), Wnt, and Runx2.
These proteins might themselves have downstream effects on osterix. A high
level of osterix expression could possibly influence the rate of differentiation and
the number of osteoblasts in the suture tissue region leading to bone deposition.
As discussed before, the lack or inactivation of osterix can have detrimental
effects causing severely undeveloped bone anatomy of the skull in mice (Baek et
al., 2009). In the present study, results propose that overexpression or
upregulation of osterix could potentially also lead to detrimental effects resulting
in overdevelopment and premature fusion of the bone tissue. Craniosynostosis
could be one such effect. Future work will hopefully provide greater insight into
the etiology of craniosynostosis. Again, surgical specimens would be collected
from Akron Children’s Hospital, dissected, processed, embedded, and sectioned
for analysis.
It is already known that osterix knock-out mice fail to form bone but to
understand further the role of osterix in normal bone development, a mouse
model could be studied. One model is the mice affected with Frank-ter Haar
syndrome, which is known to induce sagittal craniosynostosis (Bendon et al.,
2012). This mouse model would allow thorough examination of both a fully
diseased and normal tissue sample from calvaria. Such a mouse model would
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overcome the limitation of the present study in which normal sagittal human
tissue from a perfectly healthy skull of an infant cannot be obtained in any
surgical instance. Frank-ter Haar mice, however, could still be used for
comparison with tissue from normal mouse counterparts. It is difficult to mimic
the nonsyndromic form of craniosynostosis in mice because the cause of the
nonsyndromic form, as its name implies, is unknown and therefore impossible to
induce in the animals.
RNA levels of osterix could be measured in diseased and normal tissue
through RNA isolation and polymerase chain reaction (PCR) analysis. If osterix
RNA expression were statistically different between the diseased and normal
tissue, then molecular genetics could be used to investigate genes encoding the
osterix protein in the diseased and normal states.
The discovery of osterix in the human craniosynostosis diseased tissue here
introduces new avenues and possibilities for understanding the condition more
completely. It would be interesting to study the molecular and cellular
mechanisms that govern osterix control of how and when osteoblast proliferation
and differentiation occur, as these are areas that remain uncertain. It is known
that osterix is present in the early stages of osteoblast proliferation and
differentiation, whereas proteins like osteocalcin, osteopontin and bone
sialoprotein are mid-to-late stage osteoblast markers. Thus osterix effects on the
complete osteoblast pathway (early to final stages) need to be investigated.
Additional studies addressing the role of osterix in the pathway could provide
clearer insight about craniosynostosis and possibly other bone pathologies.
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The current treatment of craniosynostosis remains traditional surgery (ranging
from minimal to invasive). The goal of corrective surgery is to treat the pathology
once it has already formed. This surgery allows any pressure on the brain to be
relieved/removed, provides ample room for the growth of the skull, and can
improve the appearance of the child. This condition can be inherited but most
cases remain sporadic. Therefore genetic counseling could be recommended to
those families that are aware of the inherited disorder. Continued research
efforts should be made to understand craniosynostosis, so the disease can be
prevented before it even occurs. Progress should be made to prevent this
problem rather than treating it after the fact. Like folic acid taken as a prenatal
vitamin during pregnancy to help prevent birth defects of the brain and spinal
cord, perhaps in the future a similar type of treatment or drug will be
recommended to pregnant women to prevent diseases like craniosynostosis in
infants.
In conclusion, this study used histological and/or immunohistochemical
analyses to study nonsyndromic sagittal synostoses as well as patent (normal
open suture) tissue obtained from the skulls of three pediatric patients in surgery
from Akron Children’s Hospital. Histological staining, including toluidine blue,
hematoxylin and eosin, and picrosirius red counterstained with alcian blue, has
been performed. The histological methods provided qualitatively describing
tissue and cell architectural shapes and gross morphology of surgical specimens.
Immunohistochemical analyses were also performed to study the presence of
osterix, and the preliminary results found osterix presence in posterior portions of
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the sagittal regions of the specimens of interest. This finding is novel. Osterix, a
critical transcription factor in bone, is known to play a vital role in osteoblast
differentiation and bone formation. Continued progress in understanding osterix
gene expression and protein synthesis and secretion will be particularly important
for gaining information and insight into craniosynostosis.
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